Prescription Drugs
"Prescription Drugs" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that cannot be sold legally without a prescription.
Descriptor ID |
D055553
|
MeSH Number(s) |
D26.670
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Prescription Drugs".
Below are MeSH descriptors whose meaning is more specific than "Prescription Drugs".
This graph shows the total number of publications written about "Prescription Drugs" by people in this website by year, and whether "Prescription Drugs" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 1 | 2 | 3 | 2010 | 2 | 5 | 7 | 2011 | 9 | 0 | 9 | 2012 | 5 | 2 | 7 | 2013 | 4 | 3 | 7 | 2014 | 3 | 1 | 4 | 2015 | 8 | 1 | 9 | 2016 | 5 | 3 | 8 | 2017 | 4 | 0 | 4 | 2018 | 3 | 0 | 3 | 2019 | 3 | 0 | 3 | 2020 | 2 | 1 | 3 | 2021 | 4 | 1 | 5 | 2022 | 4 | 0 | 4 | 2023 | 4 | 0 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Prescription Drugs" by people in Profiles.
-
Black JC, Burkett HL, Rockhill KM, Olson R, Dart RC, Iwanicki J. Initiation Patterns and Transitions Among Adults Using Stimulant Drugs: Latent Transition Analysis. J Med Internet Res. 2023 10 05; 25:e46747.
-
DiStefano MJ, Kang SY, Parasrampuria S, Anderson GF. Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance. JAMA Health Forum. 2023 05 05; 4(5):e231090.
-
Bushnell G, Sun JW, dosReis S, Camelo Castillo W, Czaja AS, Durrieu G, Gerhard T, Lee H, Kaguelidou F, Pudasainee-Kapri S, Raman SR, Spence O, Horton DB. Geographic Trends in Pediatric Psychotropic Medication Dispensing Before and After the Start of the COVID-19 Pandemic. Psychiatr Serv. 2023 08 01; 74(8):880-884.
-
Shih YT, Yabroff KR, Bradley CJ. Prescription Drug Provisions in the Inflation Reduction Act: Any Relief of Financial Hardship for Patients With Cancer? JAMA Oncol. 2023 02 01; 9(2):165-167.
-
Brockie TN, Campbell JC, Dana-Sacco G, Farley J, Belcher HME, Kub J, Nelson KE, Ivanich JD, Yang L, Wallen G, Wetsit L, Wilcox HC. Cultural Protection from Polysubstance Use Among Native American Adolescents and Young Adults. Prev Sci. 2022 10; 23(7):1287-1298.
-
Butler H, Rice JD, Carlson NE, Morrato EH. A flexible mixed-data model applied to claims data for post-market surveillance of prescription drug safety behavior. Pharm Stat. 2022 09; 21(5):1022-1036.
-
Hockenhull J, Wood DM, Fonseca F, Guareschi M, Scherbaum N, Iwanicki JL, Dart RC, Dargan PI. The association between the availability of over the counter codeine and the prevalence of non-medical use. Eur J Clin Pharmacol. 2022 Jun; 78(6):1011-1018.
-
Gallegos N, Fitzgerald L, Versackas A, Sherer E, Valdez C. Improving Organizational Sustainability of an Urban Indian Health Clinic With an Innovative Pharmacy Model. J Prim Care Community Health. 2022 Jan-Dec; 13:21501319211069750.
-
Barocas JA, Savinkina A, Adams J, Jawa R, Weinstein ZM, Samet JH, Linas BP. Clinical impact, costs, and cost-effectiveness of hospital-based strategies for addressing the US opioid epidemic: a modelling study. Lancet Public Health. 2022 01; 7(1):e56-e64.
-
Black JC, Forber A, Severtson SG, Rockhill K, May KP, Amioka E, Schwarz J, Iwanicki J, Dart RC. Drug product dispensing and estimates of use in a general population survey as a signal detection problem. Pharmacoepidemiol Drug Saf. 2021 08; 30(8):1132-1139.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|